Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 5,847 | 4,271 | 4,936 | 1,632 | 710 |
| Operating Income | -5,847 | -4,271 | -4,936 | -1,632 | -710 |
| Interest Expense | 0 | 0 | 1 | 1 | 1 |
| Other Income | 96 | 385 | 11,753 | -187 | 0 |
| Pre-tax Income | -5,752 | -3,886 | 6,817 | -1,820 | -711 |
| Net Income Continuous | -5,752 | -3,886 | 6,817 | -1,820 | -711 |
| Net Income | $-5,752 | $-3,886 | $6,817 | $-1,820 | $-711 |
| EPS Basic Total Ops | -1.10 | -0.75 | 1.82 | -0.53 | -0.21 |
| EPS Basic Continuous Ops | -1.10 | -0.75 | 1.82 | -0.53 | -0.21 |
| EPS Diluted Total Ops | -1.10 | -0.75 | 1.47 | -0.53 | -0.21 |
| EPS Diluted Continuous Ops | -1.10 | -0.75 | 1.47 | -0.53 | -0.21 |
| EBITDA(a) | $-5,816 | $-4,227 | $-4,917 | $-1,584 | $-703 |